Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

11 Results

Guidelines and Advice

Follow-up for Cervical Cancer

Status: In-Review
ID: 4-16
Version: 2

May 2015

Guidelines and Advice

Follow-up After Primary Therapy for Endometrial Cancer

Status: Current
ID: 4-9
Version: 2

Jun 2017

Guidelines and Advice

Focal Tumour Ablation: Transarterial Chemoembolization for Hepatocellular Carcinoma

Status: In-Review
ID: FA 2

Mar 2015

Guidelines and Advice

Focal Tumor Ablation: Thermal Ablation of Hepatocellular Carcinoma and Metastases from Colorectal Carcinoma

Status: In-Review
ID: FA 1

Jul 2014

Guidelines and Advice

Fulvestrant for Systemic Therapy of Locally Advanced or Metastatic Breast Cancer in Postmenopausal Women: Guideline Recommendations

Status: Archived
ID: 1-13

Sep 2008

Guidelines and Advice

Focal Tumour Ablation for Renal Cell Carcinoma

Status: Current
ID: FA3

Aug 2016

Guidelines and Advice

Focal Tumour Ablation: Early-stage Primary Lung Cancer and Lung Metastases

Status: Current
ID: FA4

Aug 2016

Guidelines and Advice

Focal Tumour Ablation in Ontario: Recommendations Report 2015

Status: Current
ID: GL-C50-19

Jan 2015

Guidelines and Advice

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Status: Current
Version: 1

Apr 2023

Guidelines and Advice

First-line treatment of advanced-stage Hodgkin lymphoma

Status: Current
ID: ES 6-25

Oct 2024

Guidelines and Advice

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Status: In-Review
ID: RR SCT-9
Version: N/A

Jun 2020